Varicose Ulcer Clinical Trial
Official title:
Clinical Study to Identify Biological Markers to Predict Wound Healing in Patients With Chronic Venous Ulceration of the Lower Limb
Chronic venous ulceration of the lower limb poses a significant problem to patients and
healthcare providers alike. 1% of the population of Western countries have either an open or
healed chronic venous ulcer.
However, the pathophysiological abnormalities are not entirely clear in how raised venous
pressure translates into the changes seen in the skin culminating in an open ulcer. The
standard treatment of this condition in the United Kingdom is to undertaken compression
bandaging of the lower limb.
In order to further their knowledge of venous ulceration, the investigators seek to
determine the biological profile of venous ulcers over a maximum of twenty-eight weeks and
by dividing the groups into healing and non-healing wounds, the investigators may be able to
demonstrate a difference in the biological profile.
This work may provide insights into predicting who will respond to treatment and targets for
treatment in the future.
Forty patients with chronic venous ulceration of the lower limb who meet the inclusion
criteria will be entered into the study and assessed over a twenty week period with
assessments at week 0, 1, 2, 4, 8, 12 and 20. Urine, serum and ulcer fluid will be sampled.
If the ulcer has not healed, further assessments using an approved biological dressing will
be undertaken at weeks 20, 21, 22, 23, 25 and 28 with further sampling of ulcer fluid, urine
and serum.
Samples will undergo metabolic profiling using established metabonomic techniques developed
at Imperial College.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02561013 -
A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers
|
N/A | |
Recruiting |
NCT05364112 -
Utilization of Compreflex Wraps in Patients With Chronic Venous Insuffciency
|
N/A | |
Completed |
NCT00656383 -
Effectiveness and Efficiency of Two Models of Delivering Care to a Chronic Wound Population
|
N/A | |
Active, not recruiting |
NCT02973893 -
Study of VF001-DP in Patients With Chronic Venous Leg Ulcers
|
Phase 2 | |
Not yet recruiting |
NCT02873728 -
Remote Ischemic Conditioning for Treatment of Chronic Wounds
|
N/A | |
Recruiting |
NCT06135246 -
Laser Therapy for Venous Leg Ulcers
|
N/A | |
Active, not recruiting |
NCT03744858 -
The Role of Pyroptosis in Chronic Venous Disease
|
||
Completed |
NCT01449422 -
Clinical Trial to Evaluate the Efficacy, Tolerance and Acceptability of URGO Dressing vs a Hydrofibre in the Local Management of Venous or Predominantly Venous Mixed Leg Ulcers.
|
Phase 4 | |
Completed |
NCT00838500 -
THERMES ET VEINES: Spa for Prevention of Leg Ulcers
|
Phase 3 | |
Completed |
NCT04039789 -
Impact of Physical Activity as a Coadjuvant Treatment in the Healing of Venous Ulcers in Primary Health Care.
|
N/A | |
Completed |
NCT04280679 -
Treatment of Insufficient Superficial and Perforatring Veins of the Lower Limb Using HIFU
|
N/A | |
Completed |
NCT02512159 -
Skin Ulcers Treatment With an Handicraft Topical Device
|
Phase 4 | |
Completed |
NCT02896725 -
Wool-derived Keratin Dressings for Venous Leg Ulcers
|
N/A | |
Completed |
NCT04310280 -
Effects of Local Insulin on Varicose Ulcers for Wound Healing
|
Phase 3 | |
Completed |
NCT02626156 -
Cooling Leg and Foot Ulcer Skin Post Healing to Prevent Ulcer Recurrence
|
Phase 2 | |
Recruiting |
NCT03127904 -
Vein Fitness System vs Compressive Therapy for Venous Ulcers: a Bayesian Adaptive Trial
|
N/A | |
Withdrawn |
NCT00648674 -
A Post-Marketing Clinical Study of Apligraf for Venous Leg Ulcers
|
Phase 4 | |
Terminated |
NCT00727701 -
Study of Individualized Wound Prevention Instruction to Prevent Venous Ulcer Development
|
Phase 1 | |
Completed |
NCT00399308 -
Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers
|
Phase 1/Phase 2 | |
Completed |
NCT00426972 -
Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor Sites
|
Phase 3 |